Soleus Capital Group, LLC
Insider CIK 1812276 · LYRA 10% owner · PBLS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-29 | 527,070 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-29 | 375,000 | $20.00 | $7.50M | 1,027,000 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-29 | 527,070 | $9.48 | $5.00M | 527,070 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-29 | 125,000 | $20.00 | $2.50M | 652,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-15 | 3,607,224 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise deriv | 2020-05-05 | 2020-05-15 | 31,382 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion deriv | 2020-05-05 | 2020-05-15 | 11,666,666 | — | $0 | 0 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | X Exercise | 2020-05-05 | 2020-05-15 | 31,382 | $8.63 | $270.8K | 474,330 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-15 | 104,608 | — | $0 | 442,948 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | C Conversion | 2020-05-05 | 2020-05-15 | 338,330 | — | $0 | 338,330 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | P Buy | 2020-05-05 | 2020-05-15 | 155,000 | $16.00 | $2.48M | 155,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2020-05-05 | 2020-05-15 | 16,909 | $16.00 | $270.5K | 457,421 | SEC↗ |